Article info

0419: A Prospective Phase I/Ii Trial of the Cyclooxyge-Nase-2 Inhibitor Celecoxib in Patients with Carcinoma of the Cervix with Biomarker Assessment of the Tumor Micro Environment

Authors

Citation

Herrera FG, Chan P, Doll C, et al
0419: A Prospective Phase I/Ii Trial of the Cyclooxyge-Nase-2 Inhibitor Celecoxib in Patients with Carcinoma of the Cervix with Biomarker Assessment of the Tumor Micro Environment
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.